Fig. 3From: 14-3-3 \(\upzeta /\updelta\)-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM214-3-3 \(\upzeta /\updelta\) discriminates carriers of amyloid β. A–C ROC analyses contrasting CSF biomarkers between AD and all other groups (A), amyloid-β positive and amyloid-β negative cognitively unimpaired (B) and amyloid β positive and amyloid β negative cognitively impaired (C) individuals. AUCs and P-values of statistical comparisons between 14-3-3 \(\upzeta /\updelta\) and all other biomarkers are shown in the figure. ROC curves were compared using Venkatraman testBack to article page